Kraig Biocraft Laboratories has assembled a team of leading biotechnology experts, and others with experience spanning critical areas of science and business. The Company has formed relationships with some of the world’s top institutions.
You can tell a lot about a Company by the company they keep:
By clicking on the links above, you will be leaving Kraig’s website. Please note that KBLB does not control and is not responsible for the content on such sites.
ANN ARBOR, Mich., – July 19, 2023 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Today marks an important milestone for Kraig Labs and, with it, the opportunity to share an update across all aspects of our operations. This letter
Ann Arbor, MI., November 21, 2022 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Ann Arbor, MI., – September 12, 2022 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development
Ann Arbor, Michigan., – August 17, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Ann Arbor, Michigan., – August 4, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
